MiR-15b-5p REGULATES THE NLRP3 INFLAMMASOME SIGNAL THROUGH TARGETING SIRT3 TO REGULATE HYPOXIA/REOXYGENATION-INDUCED CARDIOMYOCYTE PYROPTOSIS PROCESS
Overview
Authors
Affiliations
Hypoxia/reoxygenation (H/R) induces pyroptosis in the setting of acute myocardial infarction (AMI). Previous studies have shown that the expression of the miR-15 family is stimulated in myocardial ischemia-reperfusion injury or H/R-induced cardiomyocyte injury, and miR-15 is a promoter of cardiac ischemia-reperfusion or H/R injury. However, whether miR-15b-5p regulates H/R injury and cardiomyocyte pyroptosis and its mechanism still need to be further clarified. Bioinformatics analysis elicited that SIRT3 was the downstream regulatory target gene of miR-15b-5p. SIRT3 has been shown to participate in the regulation of pyroptosis by negatively regulating the NLRP3 inflammasome pathway. Therefore, we hypothesized that miR-15b-5p targets SIRT3 and activated the NLRP3 inflammasome pathway to promote H/R-induced cardiomyocyte pyroptosis. We first show that H/R increases miR-15b-5p in rat cardiomyocytes H9C2. Next, we tested the effects of inhibition of miR-15b-5p or overexpression of SIRT3. We found that miR-15b-5p downregulation or SIRT3 overexpression could reverse the H/R-induced pyroptosis. Furthermore, silencing SIRT3 antagonized the protective effect of miR-15b-5p downregulation on H9C2 cells. NLRP3 inhibitor MCC950 annulled the previously mentioned antagonistic effect of silencing SIRT3 on the protection of miR-15b-5p downregulation against pyroptosis. We then used a rat AMI model to analyze myocardial infarction area by triphenyl tetrazolium chloride staining and assess serum cardiac troponin T level by ELISA and found that miR-15b-5p silencing reduced AMI injury in rats. Collectively, these results suggest that miR-15b-5p increase H/R-induced pyroptosis in cardiomyocytes by targeting SIRT3 and activating the NLRP3 inflammasome.
Programmed cardiomyocyte death in myocardial infarction.
Wu H, Lan Q, He Y, Xue J, Liu H, Zou Y Apoptosis. 2025; .
PMID: 39833636 DOI: 10.1007/s10495-025-02075-3.
MicroRNA Regulation for Inflammasomes in High Glucose-Treated ARPE-19 Cells.
Kim J, Yu H, Kang J, Hong E, Kang M, Seong M J Ophthalmol. 2024; 2024:3654690.
PMID: 39220230 PMC: 11366061. DOI: 10.1155/2024/3654690.
Martino E, DOnofrio N, Balestrieri A, Mele L, Sardu C, Marfella R Cell Mol Biol Lett. 2023; 28(1):66.
PMID: 37587410 PMC: 10428548. DOI: 10.1186/s11658-023-00482-5.
A bibliometric analysis of myocardial ischemia/reperfusion injury from 2000 to 2023.
Wang Y, Guo L, Zhang Z, Fu S, Huang P, Wang A Front Cardiovasc Med. 2023; 10:1180792.
PMID: 37383699 PMC: 10293770. DOI: 10.3389/fcvm.2023.1180792.
MicroRNA in the Diagnosis and Treatment of Doxorubicin-Induced Cardiotoxicity.
Kuang Z, Wu J, Tan Y, Zhu G, Li J, Wu M Biomolecules. 2023; 13(3).
PMID: 36979503 PMC: 10046787. DOI: 10.3390/biom13030568.